Our investigations are supported by research grants from national and international competitive calls from public and private institutions. Donations to increase the competitiveness of our research are welcome.


Funded research projects

2022-25. Targeting excitatory neural circuits in Alzheimer’s disease. A2022047S. Standard Award Program in Alzheimer’s disease research. BrightFocus Foundation (USA).

Biomarkers for early diagnosis of cognitive decline in dementia. PDC2021-121350-I00. Proyectos I+D+I Prueba de Concepto 2021. Ministerio de Ciencia e Innovación (Spain).

2020-22. Synaptic interactome and transcriptome of the synaptonuclear factor CRTC1 in Alzheimer’s disease transgenic mice. PID2019-106615RB-I00. Ministerio de Ciencia e Innovación (Spain).

2017-19. Transcriptional mechanisms of synaptic plasticity in memory circuits in a mouse mouse of neurodegeneration (MESYMEC). SAF2016-80027-R. Ministerio de Ciencia, Innovación y Universidades (Spain).

2019. Evaluation of novel compounds to enhance neuronal activity in Alzheimer’s disease. 2018 Llavor 00053. Program Ajuts d’Industria del Coneixement Llavor. Granted with FEDER funds by Agencia Gestió Ajuts Universitaris i Recerca (AGAUR), Secretaria d’Universitat i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya.

Molecular mechanisms underlying neuron dysfunction and degeneration in pathological conditions. Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED). Instituto Carlos III. Ministerio de Economía, Industria y Competitividad (Spain).

Transcriptional mechanisms of memory loss in Alzheimer’s disease. A2014417S. Standard Award Program in Alzheimer’s disease research. BrightFocus Foundation (USA).

2014-16. Transcriptional mechanisms underlying memory loss in Alzheimer’s disease transgenic mouse models (TRANSMECAD). SAF2013-43900-R. Ministerio de Economía y Competitividad (Spain).

2012-16. ICREA Academia Research Grant. Generalitat de Catalunya.

2011-13. Transcriptome analysis of Alzheimer’s disease transgenic mice (TRANSCRIPTOMAD). SAF2010-20925. Ministerio de Economía y Competitividad (Spain).

2008-11. Memory loss in Alzheimer’s disease: underlying mechanisms and therapeutic targets (MEMOSAD). FP2007-200611. 7th Framework Programme-Health. European Comission.


2012. ICREA Academia Research Award

Excellence Research Groups, Generalitat de Catalunya.
2005 SGR 01073, 2009 SGR 01231, 2014 SGR 0984 and 2017 SGR 749.


VII International Ciiien-Ciberned Congress
Valencia 17-20, 2019.

© Casa de S.M. el Rey